指南与共识乳腺US乳腺X线

COVID-19疫苗接种相关腋窝淋巴结病:23例女性影像表现与随访建议

COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women.
指南 / 共识 · AJR Am J Roentgenol · 2021-02-24

本文报告23例近期接种COVID-19疫苗后乳腺影像发现腋窝淋巴结病的女性。13%有腋窝肿块症状,43%为筛查,43%因其他原因诊断性成像。BI-RADS 2类1例,3类21例(超声随访4-24周),4类1例。放射科医生需熟悉循证指南,避免对疫苗接种后反应性淋巴结病进行不必要的随访成像和活检。

要点

  • 近期COVID-19疫苗接种后乳腺影像可发现腋窝淋巴结病,多为反应性。
  • 本组43%为筛查,43%因其他原因诊断性成像,13%有腋窝肿块症状。
  • BI-RADS 3类占21例,超声随访间隔4-24周;BI-RADS 4类仅1例。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The purpose of this article is to report on 23 women with evidence of axillary adenopathy at breast imaging after recent COVID-19 vaccination. A total of 13% of patients had symptoms (axillary lump), 43% were undergoing screening, and 43% were undergoing diagnostic imaging for other reasons. BI-RADS category 2 was assigned in one case, BI-RADS 3 in 21 (ultrasound in 4-24 weeks), and BI-RADS 4 in one. Radiologist familiarity and evidence-based guidelines are needed to avoid follow-up imaging and biopsies for reactive adenopathy after COVID-19 vaccination.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Mortazavi S. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women. AJR Am J Roentgenol. 2021. PMID: 33624520. doi:10.2214/AJR.21.25651

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。